Karuppiah Kannan, associate director at Takeda Pharmaceuticals, talks about the progress made in treating myeloma and where the field is going in the future.
Karuppiah Kannan
Advertisement
Articles by Karuppiah Kannan
Karuppiah Kannan, associate director at Takeda Pharmaceuticals, discusses what it was like as a researcher to meet with patients during the Moving Mountains for Multiple Myeloma Grand Canyon hike.
Advertisement
Latest Updated Articles
Bridging the Researcher-Patient GapPublished: July 29th 2016 | Updated:
- Karuppiah Kannan on the Past and Future of Myeloma Treatment
Published: August 4th 2016 | Updated:
Advertisement
Advertisement
Trending on CURE
1
FDA Approves First Interchangeable Biosimilar to Perjeta in HER2+ Breast Cancer
2
Cancer Experts Share Emerging Treatments Patients Should Know in 2026
3
FDA Approves Komzifti for NPM1-Mutant Acute Myeloid Leukemia
4
Shared Loss Leads to Lifelong Friendship in Rare Cancer Caregiving
5
